To check Oneindia News on your Mobile
go to:   http://m.oneindia.in/news/
  •  

Dialysis safe for kidney patients who have suffered heart attack

Washington, July 10 (ANI): Dialysis treatment doesn't have any adverse impact on kidney patients who have suffered a heart attack, say researchers.

People with even mild forms of kidney disease have an elevated risk of heart attack.

Those with end-stage renal disease (ESRD) are particularly vulnerable and often experience a heart attack while undergoing kidney disease treatments such as dialysis.

During the study, Dr George Coritsidis, Elmhurst/Queens Hospital Centre/Mount Sinai School of Medicine, reviewed the medical charts of 131 ESRD patients who had a heart attack while they were on dialysis.

They looked to see if the timing of dialysis had any effect on patients' heart health following their heart attack. About half of the patients received dialysis within the first 24 hours of their heart attack.

The results showed no link between the timing of dialysis treatments and cardiac symptoms, such as chest pains or emergency room admissions.

Though a similar number of patients in each of the three groups experienced cardiac symptoms, the researchers have identified several predictors that might indicate which dialysis patients have a particularly high risk.

These include the seriousness of the patient's condition, prior heart disease, high pre-dialysis potassium blood levels, and a large drop in potassium blood levels after dialysis.

"In conclusion, our study does not indicate that timing of dialysis poses a risk. What may be of greater importance is the potassium status, its treatment, and the severity of the patients' condition on admission," the authors wrote.

"Given that this is a retrospective as well as a small study, we cannot make any clear recommendations, however our findings suggest that rather than delay dialysis, concern should be placed on the degree and rate that potassium levels change," they added.

The study appears in Clinical Journal of the American Society Nephrology (CJASN). (ANI)

Aspirin and anti-clotting drug's combo reduces dialysis access failure risk

Washington, May 21 (ANI): A combination of aspirin and the anti-platelet drug dipyridamole could significantly reduce blockages and extend the life of new artery-vein access grafts used for hemodialysis, according to study by the Dialysis Access Consortium (DAC).Very often, artery-vein access grafts, called arteriovenous (AV) grafts, fail due to narrowing of blood vessels (stenosis) at the graft site and subsequent clotting, which block the flow of blood.And a blocked graft becomes useless for dialysis and is a major cause.....
User Comments
[ Post Comments ]
Be the first to comment on this article.
Oneindia  Oneindia Login